Lijecnicki vjesnik 2017;139(11-12)
GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING PATIENTS WITH NON-SMALL CELL LUNG CANCER
Miroslav Samaržija, Marko Jakopović, Marijo Boban, Lidija Bošković, Ingrid Belac Lovasić, Antonio Juretić, Damir Gugić, Jasna Radić, Sven Seiwerth, Snježana Tomić, Ksenija Lučin, Sanja Pleština, Mihovil Roglić, Joško Juričić, Silvana Smojver Ježek, Dinko Stančić-Rokotov, Ivica Mažuranić, Suzana Kukulj, Krešimir Dolić, Dragan Arar, Melita Kukuljan, Eduard Vrdoljak
Abstract
Lung cancer is the most common male cancer, and one of the most common female cancers. Non-small cell lung cancers account for 85% of lung cancers. Due to the aggressiveness of the disease and bad prognosis if it is not diagnosed early, it is important to define and implement standardized approach for diagnostics, treatment and monitoring of these patients. Treatment modalities include surgery, chemotherapy, radiotherapy, targeted biologic therapy and immunotherapy according to the stage, specific tumour histological subtype and patient condition.